These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 28662704

  • 21. Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
    Stabile E, Izzo R, Rozza F, Losi MA, Coscioni E, Trimarco B.
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):115-22. PubMed ID: 27207360
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.
    Goldhaber SZ, Schulman S, Eriksson H, Feuring M, Fraessdorf M, Kreuzer J, Schüler E, Schellong S, Kakkar A.
    Thromb Haemost; 2017 Nov; 117(11):2045-2052. PubMed ID: 29202209
    [Abstract] [Full Text] [Related]

  • 25. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?
    Hammwöhner M, Goette A.
    J Cardiovasc Pharmacol; 2015 Dec; 66(6):530-9. PubMed ID: 26222990
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Dabigatran as a therapeutic possibility in heparin-induced thrombocytopenia type II].
    Anniccherico FJ, Alonso JL, Urbieta M, Pérez Ricarte S.
    An Sist Sanit Navar; 2012 Dec; 35(3):521-4. PubMed ID: 23296239
    [Abstract] [Full Text] [Related]

  • 37. Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
    Pallisgaard JL, Lindhardt TB, Hansen ML, Schjerning AM, Olesen JB, Staerk L, Torp-Pedersen C, Gislason GH.
    PLoS One; 2015 Dec; 10(10):e0141377. PubMed ID: 26513589
    [Abstract] [Full Text] [Related]

  • 38. Drug Treatment of Venous Thromboembolism in the Elderly.
    Boey JP, Gallus A.
    Drugs Aging; 2016 Jul; 33(7):475-90. PubMed ID: 27255713
    [Abstract] [Full Text] [Related]

  • 39. [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
    Meddahi S, Samama MM.
    J Mal Vasc; 2011 Feb; 36(1):24-32. PubMed ID: 21239127
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.